Keyphrases
Logistic Regression
100%
Southeast Asian
100%
Fibrosis
100%
Non-alcoholic Fatty Liver Disease (NAFLD)
100%
Asian Patients
100%
Blood Markers
100%
Blood Logistics
100%
Advanced Fibrosis
60%
Liver Biopsy
40%
China
20%
Fasting Plasma Glucose
20%
Diabetes
20%
Impaired Fasting Glucose
20%
Body Mass Index
20%
Disease Treatment
20%
Malaysia
20%
Triglycerides
20%
Area under the ROC Curve
20%
Alanine Aminotransferase
20%
Hypothesis Testing
20%
India
20%
Receiver Operating Characteristic Curve
20%
Aspartate Transaminase
20%
Validation Set
20%
Area under the Receiver Operating Characteristic Curve
20%
Treatment Decisions
20%
Count Rate
20%
Web Tool
20%
Platelet Count
20%
Model Building
20%
Diagnostic Ability
20%
Disease Surveillance
20%
Fibrosis-4 (FIB-4)
20%
Non-invasive Diagnosis
20%
Stepwise Logistic Regression
20%
Fast Access
20%
Medical Tests
20%
Glutamyltransferase
20%
Nonalcoholic Fatty Liver Disease Activity Score
20%
Biochemistry, Genetics and Molecular Biology
Glucose Blood Level
100%
Transaminase
50%
Alanine
50%
Triglyceride
50%
Body Mass
50%
Aspartate Transaminase
50%
Gamma-Glutamyl Transpeptidase
50%
Platelet Count
50%
Focused Ion Beam
50%
Medicine and Dentistry
Logistic Regression Analysis
100%
Nonalcoholic Fatty Liver
100%
Fibrosis
100%
Liver Biopsy
25%
Diagnosis
12%
Diabetes
12%
Body Mass Index
12%
Triacylglycerol
12%
Alanine Aminotransferase
12%
Platelet
12%
Blood Glucose
12%
Aspartate Aminotransferase
12%
Gamma-Glutamyl Transpeptidase
12%
Disease Surveillance
12%
Focused Ion Beam
12%
Non Invasive Measurement
12%
Pharmacology, Toxicology and Pharmaceutical Science
Fibrosis
100%
Nonalcoholic Fatty Liver
100%
Combination Therapy
12%
Triacylglycerol
12%
Alanine Aminotransferase
12%
Disease Surveillance
12%
Aspartate Aminotransferase
12%
Focused Ion Beam
12%
Gamma Glutamyltransferase
12%
Immunology and Microbiology
Non-Alcoholic Fatty Liver Disease
100%
Glucose Blood Level
33%
Alanine
16%
Body Mass
16%
Platelet Count
16%